Impact of crossover and baseline prognostic factors on overall survival (OS) with abiraterone acetate (AA) in the COU-AA-302 final analysis Meeting Abstract


Authors: Ryan, C. J.; Smith, M. R.; Fizazi, K.; Saad, F.; Sternberg, C. N.; Logothetis, C.; Small, E. J.; Carles, J.; Flaig, T. W.; Taplin, M. E.; Higano, C. S.; De Souza, P. L.; de Bono, J. S.; Griffin, T. W.; De Porre, P.; Park, Y. C.; Li, J. H.; Kheoh, T. S.; Molina, A.; Rathkopf, D. E.
Abstract Title: Impact of crossover and baseline prognostic factors on overall survival (OS) with abiraterone acetate (AA) in the COU-AA-302 final analysis
Meeting Title: 2015 Genitourinary Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 33
Issue: 7 Suppl.
Meeting Dates: 2015 Feb 26-28
Meeting Location: Orlando, FL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2015-03-01
Language: English
ACCESSION: WOS:000356886700144
PROVIDER: wos
DOI: 10.1200/jco.2015.33.7_suppl.142
Notes: Meeting Abstract: 142 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Dana Elizabeth Rathkopf
    272 Rathkopf